ARTICLE | Company News
Immune Pharmaceuticals, Weizmann Institute of Science deal
May 28, 2012 7:00 AM UTC
Immune partnered with Yeda Research and Development Company Ltd., the institute's technology transfer arm, to develop antibodies against epidermal growth factor receptor 3 ( EGFR3; HER3; ErbB3) for...